Telemedicine and Weight Loss Stocks to Watch

 

Telemedicine and Weight Loss Stocks to Watch

 

Stocks Discussed: Integrated Ventures, Inc. (OTCQB: $INTV), Hims & Hers Health Inc. (NYSE: $HIMS), LifeMD, Inc. (Nasdaq: $LFMD), 23andMe Holding Co. (Nasdaq: $ME)

 

September 4,  2024 - Investorideas.com, a go-to investing platform covering health and wellness issues a snapshot looking at news and developments for the telemedicine and weight loss market, featuring new player in the market, Integrated Ventures, Inc. (OTCQB: INTV), a portfolio holdings company, focused on e-commerce technology, digital assets and consumer-focused investments.

 

According to Meticulous Research, the global telehealth market is set to experience significant growth, with an anticipated CAGR of 21.6% from 2022 to reach $539.73 billion by 2029. This robust expansion is primarily driven by several key factors, including the rising elderly population, the increasing incidence of chronic diseases, supportive government policies, and heightened awareness of telehealth benefits.

 

Research and Markets reports, “The United States Telehealth Market was valued at USD 21.11 Billion in 2023 and is expected to reach USD 35.58 Billion by 2030 with a CAGR 8.95%.”

 

Focusing on the growing trend of telemedicine and weight loss, Integrated Ventures, Inc. (OTCQB: INTV), just announced the formation and launch of their second, fully funded, 100% owned subsidiary - MedWellDirect, LLC, a Direct-To-Consumer (D2C) telemedicine solutions provider, mainly for weight loss and GLP-1 products as well as the acquisition of a 51% stake in GetTrim.Com™, owned by Healthy Lifestyle USA – an innovative telemedicine weight loss services provider.

 

Paid news dissemination for INTV

 

Read this article, featuring INTV in full at https://www.investorideas.com/news/2024/biotech/09041Telemedicine-and-Weight-Loss-Stocks.asp

 

This strategic move positions Integrated Ventures at the forefront of the rapidly expanding medical weight loss industry, which is experiencing significant growth driven by the increasing consumer adoption of new, weight loss medications such as Semaglutide and Tirzepatide.

 

Healthy Lifestyle USA has developed and launched two consumer-targeted platforms, GetTrim.Com and JoinTrim.Com, each offering unique and effective weight loss solutions, tailored to a wide audience. The dual-platform strategy, supported by advanced technological infrastructure and sophisticated marketing funnels, is designed to deliver accessible, effective and personalized weight loss services. By integrating cutting-edge telemedicine capabilities with a robust tech stack, Healthy Lifestyle USA, aims to create seamless, high-quality solutions and experiences for consumers, seeking safe and effective medical weight loss options.

 

The acquisition comes at a pivotal moment for the industry. Companies like Hims & Hers Health Inc., with a 3.2+ billion market cap, and Ro, have demonstrated the immense potential in this market, indicating a strong shift toward telemedicine-based weight loss solutions. The GetTrim and JoinTrim platform is trademarked and well-positioned to build on this success with its integrated telemedicine platforms for online consultations, real-time customer communication and secure transactions. By leveraging outsourced customer service models and third-party marketing funnels, the program is strategically designed to enhance user experience and achieve high conversion rates.

 

More from the news: Healthy Lifestyle USA’s platforms are built on a unified, cloud-based architecture that offers scalability, reliability, and security, compliant with HIPAA and GDPR regulations. Advanced reporting and analytics provide real-time insights into user behavior and treatment outcomes, utilizing machine-learning algorithms to enhance user experience and service delivery. The intuitive user interface ensures a seamless experience across all devices and telehealth features, further enhancing the comprehensive e-commerce functionalities.

 

Compliant with regulations to operate and provide medical consulting services in 49 states, including major markets like California, Florida, Texas, and New York, the GetTrim platform is well-positioned to reach a broad audience across the United States. This extensive reach aligns with Integrated Ventures' growth strategy to become a leading player in the medical weight loss sector.

 

More from the news Steve Rubakh, CEO of Integrated Ventures, Inc., commented, "The acquisition of GetTrim.Com is the engine to our multi-faceted B2C/D2C growth strategy and reinforces our commitment to investing in high-growth sectors. The GetTrim program, with its dual-platform approach and cutting-edge technology, is uniquely positioned to address the growing consumer demand for medical weight loss solutions like Semaglutide and Tirzepatide. We are excited to work closely with the Healthy Lifestyle USA team to scale these platforms, enhance user experience, and drive long-term shareholder value. Note that additional details related to this transactions are available via 8K, filed with SEC."

 

Showing the growth potential of the sector, Hims & Hers Health Inc. (NYSE: HIMS), the leading health and wellness platform, on August 5^th  announced financial results for the second quarter ended June 30, 2024 in a shareholder letter that is posted at investors.hims.com.

 

"Our second quarter results mark an acceleration in what was already an incredible trajectory. During the quarter, subscribers on our platform approached 1.9 million, increasing 43% year-over-year," said Andrew Dudum, co-founder and CEO. "We believe access to life-changing solutions should be simple, convenient, affordable, and designed for the individual. As we expand the capabilities on our platform, we are only more convinced that we can help an individual in every household in the country feel great."

 

From the news: Yemi Okupe, CFO, stated, "An approach to democratizing access to high-quality personalized solutions on our platform at an affordable price continues to resonate with consumers. We are seeing this improve our ability to attract new users to longer-tenured specialties, while also allowing us to more rapidly scale new specialties. During the second quarter, these dynamics drove an acceleration in revenue growth and record profitability levels. We are updating our full year outlook to reflect this improving momentum and continue to believe we are on a clear path toward serving tens of millions of customers as we scale this increasingly powerful and efficient model."

 

On August 7^th, LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, reported financial results for the three and six months ended June 30, 2024.

 

From the news: Management Commentary

 

“LifeMD’s core telehealth business had a very strong quarter, led by continued outperformance in our GLP-1 weight management offering. Telehealth revenue increased 67% over the prior year and our patient subscriber base grew to approximately 254,000 by quarter end. Importantly, our telehealth business became profitable on an adjusted EBITDA basis, one quarter ahead of guidance,” said Justin Schreiber, Chairman and CEO of LifeMD. “The demand we continue to generate for our virtual care services and pharmacy offerings is indicative of the significant market opportunity that exists for the convenient and affordable access to high-quality healthcare our telehealth platform and affiliated medical group offers. What we continue to demonstrate, quarter over quarter, is that we have a sustainable and now profitable business that is well positioned to leverage the transformational shift that is occurring in how consumers access healthcare.”

 

“WorkSimpli’s performance during the quarter was pressured by an unexpectedly challenging advertising environment for its products and executional issues, which have since been addressed by their leadership. Based on its current operational performance and following recent strategic efforts, we expect WorkSimpli’s financial results to improve in the second half of the year, and to return to peak profitability by year-end 2024 on a monthly run-rate basis with significant growth in 2025. While we remain confident in our ability to monetize this non-core asset, we expect our core telehealth business will be the driving force of long-term growth in revenue and profitability,” he added.

 

“We are extremely pleased with the performance of our telehealth business, which led to positive net cash flow for LifeMD on a consolidated basis. On a standalone basis, this business posted cash flow from operations of approximately $3 million for the quarter and generated positive adjusted EBITDA,” commented Marc Benathen, Chief Financial Officer of LifeMD. “Our core telehealth business’ performance continues to be ahead of expectations and, as such, we are raising our 2024 telehealth revenue guidance to $150 million from $140 million previously and are introducing adjusted EBITDA guidance for telehealth of $3 to $4 million, both ahead of previous expectations. Despite the outperformance of telehealth, due to WorkSimpli’s first half results we are revising 2024 consolidated adjusted EBITDA guidance to $13 million to $15 million, with no change to consolidated revenue guidance. We remain bullish on the consolidated business led by our core telehealth platform, which remains well positioned as the long-term growth driver.”

 

On  August 28^th, Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., (Nasdaq: ME), and a leading telemedicine provider, announced it is now offering Ozempic®, Wegovy® and compounded semaglutide through a weight loss program on its telehealth platform, providing consumers with access to affordable weight management care through a convenient subscription-based model.

 

If prescribed, Lemonaid Health patients will now have access to once-weekly injectable GLP-1 medication offerings through an accessible monthly membership subscription that includes clinician consultations (via video or phone), a GLP-1 prescription (additional cost), ongoing care and support, as well as an annual lab order (as needed).

 

“We are excited to be helping our customers get access to potentially life changing weight management programs and GLP-1 medication through Lemonaid Health and 23andMe,” said Anne Wojcicki, CEO and Co-Founder of 23andMe. “We are focused on helping customers live healthier, longer lives and believe weight management is an important pillar. We also remain enthusiastic as we see encouraging research come out about additional applications for GLP-1s and ways they may be able to prevent or mitigate disease.”

 

From the news: After an initial consultation with a clinician to confirm eligibility and medication preference, the membership is $49 per month with no long-term commitment required, and transparent medication pricing that doesn’t change based on dosage amount. Medication is charged separately starting at $299 a month for compounded semaglutide. Lemonaid provides fast shipping directly to patients, and purchases may be eligible for payment via HSA and FSA programs.

Marketdata estimates that the market for telehealth weight loss services was worth $6.9 billion in 2023. Revenues are forecast to grow 8.2% in 2024, and 7.5% annually to 2028.

 

Continued: The average weight loss telehealth service user has 5 follow-up visits per year, at a cost of $50 per visit. Monthly subscription fees cost $30-80, so the average user spends about $610 per year, not including the cost of the medications. This estimate is likely conservative.

 

Telehealth and weight loss appear to be a perfect marriage for growth for the stocks capitalizing on this trend based on recent earning reports from some of the key players, but as always, there are winners and losers in every sector and investors need to do their due diligence.

 

Research and find more biotech and telemedicine stocks at Investorideas.com

https://www.investorideas.com/BIS/Stock_List.asp

 

About Investorideas.com

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more.

 

Disclaimer/Disclosure: This news article featuring - Integrated Ventures, Inc. (OTCQB: INTV) is a paid for news release creation and dissemination on Investorideas.com.  Our site does not make recommendations for purchases or sale of stocks, services or products.  This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services and prices on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com

800-665-0411

 

Biotech Industry Stocks- investing ideas in biotechnology stocks, medical technology and life sciences

Get more biotech and medical tech news, articles, podcasts and stock directories

 

 

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

Breaking Mining Stock News: New Destiny Mining (TSXV: $NED.V) Discovers New Spokane Vein - Outcrops Sampled 35 Meters Apart 6.6% Copper and 100 G/T Silver Using XRF Spot Analysis - Treasure Mountain Silver Project, Hope BC; @NEDminingcorp

Breaking Mining Stock News: New Destiny Mining (TSXV: $NED.V) Discovers New Spokane Vein - Outcrops Sampled 35 Meters Apart 6.6% Copper and 100 G/T Silver Using XRF Spot Analysis - Treasure Mountain Silver Project, Hope BC; @NEDminingcorp

 

Vancouver, British Columbia - September 3, 2024 (Investorideas.com Newswire) New Destiny Mining Corp. (TSXV: NED), (the "Company" or "NED") provides an update on results of prospecting done in conjunction with the 2024 drilling program at the Treasure Mountain project, near Princeton, BC.

 

Prospecting north if the Jim Kelly occurrence located highly mineralized vein material (release dated August 7, 2024). Recent follow-up prospecting upslope located the Spokane quartz vein, mineralized with up to 20% coarse chalcopyrite and pyrite. The vein was sampled in two outcrops 35 meters apart (see photos) where it ranges from 0.35 to 1.0 meter in thickness. Portable XRF spot analysis results up to 6.6 percent copper and 100 grams per tonne silver were obtained, indicating base and precious metal potential (gold content cannot be determined using this instrument).

 

The vein aligns with an east-west lineament identified from high-resolution LiDAR data acquired in 2022. Based on this interpretation, the vein has a potential strike length of 500 meters (see map below). This highlights the excellent discovery potential of this area. The samples are now being sent to the lab for assays and ICP analyses. Further prospecting efforts are planned in this area. The company will be applying for permits for future trenching and drilling. Additionally, an airborne magnetic survey at the property scale is being considered.

 

Paid news dissemination on behalf of New Destiny Mining.

 

Read this news, featuring NED in full at https://www.investorideas.com/news/2024/09031NED-New-Spokane-Vein.asp

 

Portable XRF (X-Ray Fluorescence) readings are semi-quantitative measurements and are used as guideline to augment the understanding of the mineralization observed. These measurements are not intended to be representative of the geochemical composition of the material measured. XRF readings are carried out using a handheld device and could be influenced by external factors. Calibrations of the equipment in the field do not always allow comparison with results of certified reference materials. For the above results, the portable XRF data do not show any contamination based on blank analyses, and the Cu and Ag values have good accuracy based on readings done on standard NIST 2710a.

 

  

Newly discovered vein north of Jim Kelly, Spokane vein (Quartz vein with up to 20% coarse grained pyrite and chalcopyrite). On left yielded 5.5 wt% Cu with 50 g/t Ag, sample on right yielded 6.6 wt% Cu and 104 g/t Ag on a portable XRF.

 

Spokane vein samples (yellow dots) and interpreted extension of veins (dashed red lines) based on LiDAR data

Readers are cautioned that historical records referred to in this News Release have been examined but not verified by a Qualified Person. Further work is required to verify that historical records referred to in this News Release are accurate.

 

Dr. Mathew Ball, P.Geo., a Qualified Person as defined by NI 43-101 and consultant to the Company, approved the technical information contained in this News Release.

 

ON BEHALF OF THE BOARD OF DIRECTORS

"Al Beaton"

Director

604-488-3900

 

Investor Relations:
Lubica Parilakova
ir@NewDestinyMining.com

 

Map showing Treasure Mountain property and targets for 2024

 

Forward Looking Information

This news release includes certain statements that constitute "forward-looking information" within the meaning of applicable securities law, including without limitation, the Company's information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include statements regarding the completion of the proposed transactions. Forward-looking statements address future events and conditions and are necessarily based upon a number of estimates and assumptions. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as "expects" or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "estimates" or "intends", or stating that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved), and variations of such words, and similar expressions are not statements of historical fact and may be forward-looking statements. Forward-looking statement are necessarily based upon several factors that, if untrue, could cause the actual results, performances or achievements of the Company to be materially different from future results, performances or achievements express or implied by such statements. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the price of gold and other metals, anticipated costs and the ability to achieve goals, and the Company will be able to obtain required licenses and permits. While such estimates and assumptions are considered reasonable by the management of the Company, they are inherently subject to significant business, economic, competitive and regulatory uncertainties and risks including that resource exploration and development is a speculative business; that environmental laws and regulations may become more onerous; that the Company may not be able to raise additional funds when necessary; fluctuating prices of metals; the possibility that future exploration, development or mining results will not be consistent with the Company's expectations; operating hazards and risks; and competition. There can be no assurance that economic resources will be discovered or developed. Accordingly, actual results may differ materially from those currently anticipated in such statements. Factors that could cause actual results to differ materially from those in forward looking statements include continued availability of capital and financing and general economic, market or business conditions, the loss of key directors, employees, advisors or consultants, equipment failures, litigation, competition, fees charged by service providers and failure of counterparties to perform their contractual obligations. Investors are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The forward-looking statements included in this news release are made as of the date hereof and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities legislation.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

 

New Destiny Mining Corp. (TSXV: NED) is a featured mining stock on Investorideas.com

 

More info on NED at Investorideas.com Visit: https://www.investorideas.com/CO/NED/  

 

Disclaimer/Disclosure: New Destiny Mining Corp. (NED.V) is a paid featured mining stock on Investor Ideas. More info:Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

 

 

Get more mining stock investor ideas- news, articles, and podcasts and stock directories

 

August Wrap-up; New Stocks in biotech, transportation, tech, mining and defense; (Nasdaq: $QNTM) (Nasdaq: $ELEV) (NYSE American: $OSTX) (NYSE: $DAL) (Nasdaq: $SNCY) (NYSE: $LUMN) (TSXV: $FAS) (NYSE: $PRM)

August Wrap-up; New Stocks in biotech, transportation, tech, mining and defense; (Nasdaq: $QNTM) (Nasdaq: $ELEV) (NYSE American: $OSTX) (NYSE: $DAL) (Nasdaq: $SNCY) (NYSE: $LUMN) (TSXV: $FAS) (NYSE: $PRM) 

 

 

 

 

August 30, 2024 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today’s roundup of stocks to watch in the biotech, transportation, tech, mining and defense sectors.

 

The newest biotech companies treat neurodegenerative and metabolic disorders and cancers respectively.

 

The latest transportation companies are airlines, while the newest tech company provides telecom and related services.

 

The latest mining company mines for silver in Peru and the newest defense company provides Fire Safety and Specialty Products.

 

Read this in full at https://www.investorideas.com/news/2024/main/08301Stocks.asp

 

Investor Ideas is always researching and searching for new stocks to add to our growing list of free stock directories. The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

New Stocks Added to the Biotech Directories:

Quantum BioPharma Ltd (Nasdaq:QNTM; CSE:QNTM) - Formerly FSD Pharma Inc - is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. ("Lucid"), FSD is focused on the research and development of its lead compound, Lucid-MS (formerly Lucid-21-302) ("Lucid-MS"). Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma invented unbuzzd™ and spun it out its OTC version to a company, Celly Nutrition, led by industry veterans. FSD retains ownership of 25.71% (March 31, 2024) of Celly Nutrition Corp. at www.cellynutrition.com. The agreement with Celly Nutrition also includes royalty payments of 7% of sales from unbuzzd ™ until payments to FSD Pharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Additionally, FSD Pharma retains a large tax loss carry forward of approximately CAD$130 million and could be utilized in the future to offset tax payable obligations against future profits. FSD Pharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical / medical uses. FSD Pharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represent loans secured by residential or commercial property.

 

Elevation Oncology, Inc. (Nasdaq: ELEV) is an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. We are leveraging our antibody-drug conjugate (ADC) expertise to advance a novel pipeline, initially targeting two clinically validated targets in oncology, Claudin 18.2 and HER3. Our lead candidate, EO-3021, is a potential best-in-class ADC designed to target Claudin 18.2 and is currently being evaluated in a Phase 1 trial (NCT05980416) in patients with advanced, unresectable or metastatic solid tumors likely to express Claudin 18.2 including gastric, gastroesophageal junction, pancreatic or esophageal cancers. Additionally, we expect to nominate a development candidate for our second program, a HER3-targeting ADC for the treatment of patients with solid tumors that overexpress HER3, in 2024.

 

OS Therapies, Inc. (NYSE American:OSTX) is a clinical stage oncology company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OST-HER2, the Company's lead asset, is an immunotherapy leveraging the immune-stimulatory effects of Listeria bacteria to initiate a strong immune response targeting the HER2 protein. The Company has completed enrollment for a 41-patient Phase 2b clinical trial of OST-HER2 in resected, recurrent osteosarcoma, with results expected in the fourth quarter of 2024. OST-HER2 has completed a Phase 1 clinical study primarily in breast cancer patients, in addition to showing strong preclinical efficacy data in various models of breast cancer. In addition, OS Therapies is advancing its next generation Antibody Drug Conjugate (ADC) platform, known as tunable ADC (tADC), which features tunable, tailored antibody-linker-payload candidates. This platform leverages the Company's proprietary silicone linker technology, enabling the delivery of multiple payloads per linker.

 

New Stocks Added to the Transportation Directories:

Delta Air Lines, Inc. (NYSE:DAL) Headquartered in Atlanta, Delta operates significant hubs and key markets in Amsterdam, Atlanta, Bogota, Boston, Detroit, Lima, London-Heathrow, Los Angeles, Mexico City, Minneapolis-St. Paul, New York-JFK and LaGuardia, Paris-Charles de Gaulle, Salt Lake City, Santiago (Chile), Sao Paulo, Seattle, Seoul-Incheon and Tokyo.

As the leading global airline, Delta's mission to connect the world creates opportunities, fosters understanding and expands horizons by connecting people and communities to each other and to their own potential. Powered by innovative and strategic partnerships with Aeromexico, Air France-KLM, China Eastern, Korean Air, LATAM, Virgin Atlantic and WestJet, Delta brings more choice and competition to customers worldwide. Delta's premium product line is elevated by its unique partnership with Wheels Up Experience. Delta is America's most-awarded airline thanks to the dedication, passion and professionalism of its people. In addition to the awards from J.D. Power and Cirium, Delta has been recognized as the top U.S. airline by the Wall Street Journal; among Fast Company's Most Innovative Companies; the World's Most Admired Airline and one of the Best 100 Companies to Work For according to Fortune; and as one of Glassdoor's Best Places to Work. In addition, Delta has been named to the Civic 50 by Points of Light for the past seven years as one of the most community minded companies in the U.S.

 

Sun Country Airlines Holdings, Inc. (Nasdaq: SNCY) is a new breed of hybrid low-cost air carrier, whose mission is to connect guests to their favorite people and places, to create lifelong memories and transformative experiences. Sun Country dynamically deploys shared resources across our synergistic scheduled service, charter, and cargo businesses. Based in Minnesota, we focus on serving leisure and visiting friends and relatives (“VFR”) passengers and charter customers and providing cargo service to Amazon, with flights throughout the United States and to destinations in Mexico, Central America, Canada, and the Caribbean.

 

New Stocks Added to the Tech Directories:

Lumen Technologies (NYSE: LUMN) connects the world. We are igniting business growth by connecting people, data, and applications – quickly, securely, and effortlessly. Everything we do at Lumen takes advantage of our network strength. From metro connectivity to long-haul data transport to our edge cloud, security, and managed service capabilities, we meet our customers' needs today and as they build for tomorrow.

 

New Stocks Added to the Mining Directories:

FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC Pink: MSLVF) (FSE: 9TZ) is a British Columbia company that holds a 100% interest in the high-grade Santas Gloria silver property, located in Peru.

 

New Stocks Added to the Defense Directories:

Perimeter Solutions, SA (NYSE: PRM)  is a leading global solutions provider, providing high-quality firefighting products and phosphorus-based specialty chemicals. The Company's business is organized and managed in two reporting segments: Fire Safety and Specialty Products. The Fire Safety business consists of formulating, manufacture and sale of fire retardants and firefighting foams that assist in combating various types of fires, including wildland, structural, flammable liquids and others. Our Fire Safety business also offers specialized equipment and services, typically in conjunction with our fire management products, to support our customers' firefighting operations. Our specialized equipment includes airbase retardant storage, mixing, and delivery equipment; mobile retardant bases; retardant ground application units; mobile foam equipment; and equipment that we custom design and manufacture to meet specific customer needs. Our service network can meet the emergency resupply needs of over 150 air tanker bases in North America, as well as many other customer locations in North America and internationally. The segment is built on the premise of superior technology, exceptional responsiveness to our customers' needs, and a "never-fail" service network. The segment sells products to government agencies and commercial customers around the world. The Specialty Products business produces and sells high quality Phosphorus Pentasulfide ("P2S5") primarily used in the preparation of lubricant additives, including a family of compounds called Zinc Dialkyldithiophosphates ("ZDDP") that provide critical anti-wear protection to engine components. P2S5 is also used in pesticide and mining chemicals applications.

 

About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all. Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for various sectors, including gaming, biotech, tech and sports. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors. Paid content is always disclosed.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter (X) https://X.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Contact Investorideas.com to be added to our stock directories or learn more about us

Dawn Van Zant and Cali Van Zant

 

800 665 0411